OpenVSafe by OpenVAERS
Search V-safe

B5D-31847-56018

3 vaccinations 2 coded responses 19 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
945 / CA
Registered
2020-12-18
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-16
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-18
    Registered in v-safe
  3. 2020-12-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Joint pains, Muscle or body aches
    Adult check-in
  4. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Diarrhea
    Adult check-in
  7. 2020-12-23
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-30
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-01-06
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-15
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-20
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-01-27
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-05
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-04-07
    Survey response — 3 months, dose 2
    MedDRA: Inflammation — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: New inflammatory akin condition
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-07
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-07-09
    Survey response — 6 months, dose 2
    MedDRA: Dermatitis — Feeling: Good
    Free text: Inflammatory skin condition
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-09-26
    Dose 3 — Pfizer-BioNTech
  18. 2021-09-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  19. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  20. 2021-10-03
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  21. 2021-10-17
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  22. 2021-10-24
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  23. 2022-02-09
  24. 2022-03-29
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  25. 2022-09-28
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-16Pfizer-BioNTech
22021-01-06Pfizer-BioNTech
32021-09-26Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 7 — 3 months, dose 2

2021-04-07

Symptoms: New inflammatory akin condition

Release 9 — 6 months, dose 2

2021-07-09

Symptoms: Inflammatory skin condition

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDermatitis ✓ ✓ ✓
SDInflammation ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release